ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vitamin K Antagonists (VKA) Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-11M9622
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Vitamin K Antagonists VKA Market Insights and Forecast to 2028
BUY CHAPTERS

Global Vitamin K Antagonists (VKA) Market Research Report 2025

Code: QYRE-Auto-11M9622
Report
August 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Bristol–Myers Squibb
Bayer
Johnson & Johnson
Genentech (Roche)
Boehringer Ingelheim
Lilly
Daiichi Sankyo
Otsuka
Astrazeneca plc
Pfizer Inc
Aspen
The Medicines Company

Vitamin K Antagonists (VKA) Market

The global market for Vitamin K Antagonists (VKA) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Vitamin K is a kind of substance with biological activity of leaf green quinone.
Rising demand from Asia-Pacific region a major driver for the growth of the market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vitamin K Antagonists (VKA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vitamin K Antagonists (VKA).
The Vitamin K Antagonists (VKA) market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vitamin K Antagonists (VKA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vitamin K Antagonists (VKA) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Vitamin K Antagonists (VKA) Market Report

Report Metric Details
Report Name Vitamin K Antagonists (VKA) Market
Segment by Type
  • Oral Vitamin K Antagonists
  • Injection Vitamin K Antagonists
Segment by Application
  • VTE
  • ACS/MI
  • AF
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche), Boehringer Ingelheim, Lilly, Daiichi Sankyo, Otsuka, AstraZeneca, Pfizer, Aspen, The Medicines Company
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Vitamin K Antagonists (VKA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Vitamin K Antagonists (VKA) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Vitamin K Antagonists (VKA) Market report?

Ans: The main players in the Vitamin K Antagonists (VKA) Market are Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche), Boehringer Ingelheim, Lilly, Daiichi Sankyo, Otsuka, AstraZeneca, Pfizer, Aspen, The Medicines Company

What are the Application segmentation covered in the Vitamin K Antagonists (VKA) Market report?

Ans: The Applications covered in the Vitamin K Antagonists (VKA) Market report are VTE, ACS/MI, AF, Others

What are the Type segmentation covered in the Vitamin K Antagonists (VKA) Market report?

Ans: The Types covered in the Vitamin K Antagonists (VKA) Market report are Oral Vitamin K Antagonists, Injection Vitamin K Antagonists

1 Vitamin K Antagonists (VKA) Market Overview
1.1 Product Definition
1.2 Vitamin K Antagonists (VKA) by Type
1.2.1 Global Vitamin K Antagonists (VKA) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral Vitamin K Antagonists
1.2.3 Injection Vitamin K Antagonists
1.3 Vitamin K Antagonists (VKA) by Application
1.3.1 Global Vitamin K Antagonists (VKA) Market Value by Application (2024 VS 2031)
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Others
1.4 Global Vitamin K Antagonists (VKA) Market Size Estimates and Forecasts
1.4.1 Global Vitamin K Antagonists (VKA) Revenue 2020-2031
1.4.2 Global Vitamin K Antagonists (VKA) Sales 2020-2031
1.4.3 Global Vitamin K Antagonists (VKA) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vitamin K Antagonists (VKA) Market Competition by Manufacturers
2.1 Global Vitamin K Antagonists (VKA) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Vitamin K Antagonists (VKA) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Vitamin K Antagonists (VKA) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vitamin K Antagonists (VKA), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vitamin K Antagonists (VKA), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vitamin K Antagonists (VKA), Product Type & Application
2.7 Global Key Manufacturers of Vitamin K Antagonists (VKA), Date of Enter into This Industry
2.8 Global Vitamin K Antagonists (VKA) Market Competitive Situation and Trends
2.8.1 Global Vitamin K Antagonists (VKA) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Vitamin K Antagonists (VKA) Players Market Share by Revenue
2.8.3 Global Vitamin K Antagonists (VKA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vitamin K Antagonists (VKA) Market Scenario by Region
3.1 Global Vitamin K Antagonists (VKA) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vitamin K Antagonists (VKA) Sales by Region: 2020-2031
3.2.1 Global Vitamin K Antagonists (VKA) Sales by Region: 2020-2025
3.2.2 Global Vitamin K Antagonists (VKA) Sales by Region: 2026-2031
3.3 Global Vitamin K Antagonists (VKA) Revenue by Region: 2020-2031
3.3.1 Global Vitamin K Antagonists (VKA) Revenue by Region: 2020-2025
3.3.2 Global Vitamin K Antagonists (VKA) Revenue by Region: 2026-2031
3.4 North America Vitamin K Antagonists (VKA) Market Facts & Figures by Country
3.4.1 North America Vitamin K Antagonists (VKA) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vitamin K Antagonists (VKA) Sales by Country (2020-2031)
3.4.3 North America Vitamin K Antagonists (VKA) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vitamin K Antagonists (VKA) Market Facts & Figures by Country
3.5.1 Europe Vitamin K Antagonists (VKA) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vitamin K Antagonists (VKA) Sales by Country (2020-2031)
3.5.3 Europe Vitamin K Antagonists (VKA) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vitamin K Antagonists (VKA) Market Facts & Figures by Region
3.6.1 Asia Pacific Vitamin K Antagonists (VKA) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vitamin K Antagonists (VKA) Sales by Region (2020-2031)
3.6.3 Asia Pacific Vitamin K Antagonists (VKA) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vitamin K Antagonists (VKA) Market Facts & Figures by Country
3.7.1 Latin America Vitamin K Antagonists (VKA) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vitamin K Antagonists (VKA) Sales by Country (2020-2031)
3.7.3 Latin America Vitamin K Antagonists (VKA) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vitamin K Antagonists (VKA) Market Facts & Figures by Country
3.8.1 Middle East and Africa Vitamin K Antagonists (VKA) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vitamin K Antagonists (VKA) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vitamin K Antagonists (VKA) Sales by Type (2020-2031)
4.1.1 Global Vitamin K Antagonists (VKA) Sales by Type (2020-2025)
4.1.2 Global Vitamin K Antagonists (VKA) Sales by Type (2026-2031)
4.1.3 Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2020-2031)
4.2 Global Vitamin K Antagonists (VKA) Revenue by Type (2020-2031)
4.2.1 Global Vitamin K Antagonists (VKA) Revenue by Type (2020-2025)
4.2.2 Global Vitamin K Antagonists (VKA) Revenue by Type (2026-2031)
4.2.3 Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2020-2031)
4.3 Global Vitamin K Antagonists (VKA) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vitamin K Antagonists (VKA) Sales by Application (2020-2031)
5.1.1 Global Vitamin K Antagonists (VKA) Sales by Application (2020-2025)
5.1.2 Global Vitamin K Antagonists (VKA) Sales by Application (2026-2031)
5.1.3 Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2020-2031)
5.2 Global Vitamin K Antagonists (VKA) Revenue by Application (2020-2031)
5.2.1 Global Vitamin K Antagonists (VKA) Revenue by Application (2020-2025)
5.2.2 Global Vitamin K Antagonists (VKA) Revenue by Application (2026-2031)
5.2.3 Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2020-2031)
5.3 Global Vitamin K Antagonists (VKA) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Vitamin K Antagonists (VKA) Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Company Information
6.2.2 Bristol-Myers Squibb Description and Business Overview
6.2.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product Portfolio
6.2.5 Bristol-Myers Squibb Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Vitamin K Antagonists (VKA) Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Company Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Johnson & Johnson Vitamin K Antagonists (VKA) Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Genentech (Roche)
6.5.1 Genentech (Roche) Company Information
6.5.2 Genentech (Roche) Description and Business Overview
6.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Genentech (Roche) Vitamin K Antagonists (VKA) Product Portfolio
6.5.5 Genentech (Roche) Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Company Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Boehringer Ingelheim Vitamin K Antagonists (VKA) Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Lilly
6.7.1 Lilly Company Information
6.7.2 Lilly Description and Business Overview
6.7.3 Lilly Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Lilly Vitamin K Antagonists (VKA) Product Portfolio
6.7.5 Lilly Recent Developments/Updates
6.8 Daiichi Sankyo
6.8.1 Daiichi Sankyo Company Information
6.8.2 Daiichi Sankyo Description and Business Overview
6.8.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Daiichi Sankyo Vitamin K Antagonists (VKA) Product Portfolio
6.8.5 Daiichi Sankyo Recent Developments/Updates
6.9 Otsuka
6.9.1 Otsuka Company Information
6.9.2 Otsuka Description and Business Overview
6.9.3 Otsuka Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Otsuka Vitamin K Antagonists (VKA) Product Portfolio
6.9.5 Otsuka Recent Developments/Updates
6.10 AstraZeneca
6.10.1 AstraZeneca Company Information
6.10.2 AstraZeneca Description and Business Overview
6.10.3 AstraZeneca Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 AstraZeneca Vitamin K Antagonists (VKA) Product Portfolio
6.10.5 AstraZeneca Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Company Information
6.11.2 Pfizer Description and Business Overview
6.11.3 Pfizer Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Pfizer Vitamin K Antagonists (VKA) Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Aspen
6.12.1 Aspen Company Information
6.12.2 Aspen Description and Business Overview
6.12.3 Aspen Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Aspen Vitamin K Antagonists (VKA) Product Portfolio
6.12.5 Aspen Recent Developments/Updates
6.13 The Medicines Company
6.13.1 The Medicines Company Company Information
6.13.2 The Medicines Company Description and Business Overview
6.13.3 The Medicines Company Vitamin K Antagonists (VKA) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 The Medicines Company Vitamin K Antagonists (VKA) Product Portfolio
6.13.5 The Medicines Company Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vitamin K Antagonists (VKA) Industry Chain Analysis
7.2 Vitamin K Antagonists (VKA) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vitamin K Antagonists (VKA) Production Mode & Process Analysis
7.4 Vitamin K Antagonists (VKA) Sales and Marketing
7.4.1 Vitamin K Antagonists (VKA) Sales Channels
7.4.2 Vitamin K Antagonists (VKA) Distributors
7.5 Vitamin K Antagonists (VKA) Customer Analysis
8 Vitamin K Antagonists (VKA) Market Dynamics
8.1 Vitamin K Antagonists (VKA) Industry Trends
8.2 Vitamin K Antagonists (VKA) Market Drivers
8.3 Vitamin K Antagonists (VKA) Market Challenges
8.4 Vitamin K Antagonists (VKA) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
Bristol–Myers Squibb
Bayer
Johnson & Johnson
Genentech (Roche)
Boehringer Ingelheim
Lilly
Daiichi Sankyo
Otsuka
Astrazeneca plc
Pfizer Inc
Aspen
The Medicines Company
List of Tables
 Table 1. Global Vitamin K Antagonists (VKA) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Vitamin K Antagonists (VKA) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Vitamin K Antagonists (VKA) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Vitamin K Antagonists (VKA) Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global Vitamin K Antagonists (VKA) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Vitamin K Antagonists (VKA) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Vitamin K Antagonists (VKA) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Vitamin K Antagonists (VKA) Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Vitamin K Antagonists (VKA), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Vitamin K Antagonists (VKA), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Vitamin K Antagonists (VKA), Product Type & Application
 Table 12. Global Key Manufacturers of Vitamin K Antagonists (VKA), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Vitamin K Antagonists (VKA) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vitamin K Antagonists (VKA) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Vitamin K Antagonists (VKA) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Vitamin K Antagonists (VKA) Sales by Region (2020-2025) & (K MT)
 Table 18. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2020-2025)
 Table 19. Global Vitamin K Antagonists (VKA) Sales by Region (2026-2031) & (K MT)
 Table 20. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2026-2031)
 Table 21. Global Vitamin K Antagonists (VKA) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region (2020-2025)
 Table 23. Global Vitamin K Antagonists (VKA) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Vitamin K Antagonists (VKA) Revenue Market Share by Region (2026-2031)
 Table 25. North America Vitamin K Antagonists (VKA) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Vitamin K Antagonists (VKA) Sales by Country (2020-2025) & (K MT)
 Table 27. North America Vitamin K Antagonists (VKA) Sales by Country (2026-2031) & (K MT)
 Table 28. North America Vitamin K Antagonists (VKA) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Vitamin K Antagonists (VKA) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Vitamin K Antagonists (VKA) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Vitamin K Antagonists (VKA) Sales by Country (2020-2025) & (K MT)
 Table 32. Europe Vitamin K Antagonists (VKA) Sales by Country (2026-2031) & (K MT)
 Table 33. Europe Vitamin K Antagonists (VKA) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Vitamin K Antagonists (VKA) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Vitamin K Antagonists (VKA) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Vitamin K Antagonists (VKA) Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific Vitamin K Antagonists (VKA) Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific Vitamin K Antagonists (VKA) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Vitamin K Antagonists (VKA) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Vitamin K Antagonists (VKA) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Vitamin K Antagonists (VKA) Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America Vitamin K Antagonists (VKA) Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America Vitamin K Antagonists (VKA) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Vitamin K Antagonists (VKA) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Vitamin K Antagonists (VKA) Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa Vitamin K Antagonists (VKA) Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Vitamin K Antagonists (VKA) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Vitamin K Antagonists (VKA) Sales (K MT) by Type (2020-2025)
 Table 51. Global Vitamin K Antagonists (VKA) Sales (K MT) by Type (2026-2031)
 Table 52. Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2020-2025)
 Table 53. Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2026-2031)
 Table 54. Global Vitamin K Antagonists (VKA) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Vitamin K Antagonists (VKA) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2020-2025)
 Table 57. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2026-2031)
 Table 58. Global Vitamin K Antagonists (VKA) Price (USD/MT) by Type (2020-2025)
 Table 59. Global Vitamin K Antagonists (VKA) Price (USD/MT) by Type (2026-2031)
 Table 60. Global Vitamin K Antagonists (VKA) Sales (K MT) by Application (2020-2025)
 Table 61. Global Vitamin K Antagonists (VKA) Sales (K MT) by Application (2026-2031)
 Table 62. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2020-2025)
 Table 63. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2026-2031)
 Table 64. Global Vitamin K Antagonists (VKA) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Vitamin K Antagonists (VKA) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2020-2025)
 Table 67. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2026-2031)
 Table 68. Global Vitamin K Antagonists (VKA) Price (USD/MT) by Application (2020-2025)
 Table 69. Global Vitamin K Antagonists (VKA) Price (USD/MT) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. Sanofi Vitamin K Antagonists (VKA) Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. Bristol-Myers Squibb Company Information
 Table 76. Bristol-Myers Squibb Description and Business Overview
 Table 77. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product
 Table 79. Bristol-Myers Squibb Recent Developments/Updates
 Table 80. Bayer Company Information
 Table 81. Bayer Description and Business Overview
 Table 82. Bayer Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Bayer Vitamin K Antagonists (VKA) Product
 Table 84. Bayer Recent Developments/Updates
 Table 85. Johnson & Johnson Company Information
 Table 86. Johnson & Johnson Description and Business Overview
 Table 87. Johnson & Johnson Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Johnson & Johnson Vitamin K Antagonists (VKA) Product
 Table 89. Johnson & Johnson Recent Developments/Updates
 Table 90. Genentech (Roche) Company Information
 Table 91. Genentech (Roche) Description and Business Overview
 Table 92. Genentech (Roche) Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. Genentech (Roche) Vitamin K Antagonists (VKA) Product
 Table 94. Genentech (Roche) Recent Developments/Updates
 Table 95. Boehringer Ingelheim Company Information
 Table 96. Boehringer Ingelheim Description and Business Overview
 Table 97. Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Boehringer Ingelheim Vitamin K Antagonists (VKA) Product
 Table 99. Boehringer Ingelheim Recent Developments/Updates
 Table 100. Lilly Company Information
 Table 101. Lilly Description and Business Overview
 Table 102. Lilly Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. Lilly Vitamin K Antagonists (VKA) Product
 Table 104. Lilly Recent Developments/Updates
 Table 105. Daiichi Sankyo Company Information
 Table 106. Daiichi Sankyo Description and Business Overview
 Table 107. Daiichi Sankyo Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. Daiichi Sankyo Vitamin K Antagonists (VKA) Product
 Table 109. Daiichi Sankyo Recent Developments/Updates
 Table 110. Otsuka Company Information
 Table 111. Otsuka Description and Business Overview
 Table 112. Otsuka Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. Otsuka Vitamin K Antagonists (VKA) Product
 Table 114. Otsuka Recent Developments/Updates
 Table 115. AstraZeneca Company Information
 Table 116. AstraZeneca Description and Business Overview
 Table 117. AstraZeneca Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. AstraZeneca Vitamin K Antagonists (VKA) Product
 Table 119. AstraZeneca Recent Developments/Updates
 Table 120. Pfizer Company Information
 Table 121. Pfizer Description and Business Overview
 Table 122. Pfizer Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 123. Pfizer Vitamin K Antagonists (VKA) Product
 Table 124. Pfizer Recent Developments/Updates
 Table 125. Aspen Company Information
 Table 126. Aspen Description and Business Overview
 Table 127. Aspen Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 128. Aspen Vitamin K Antagonists (VKA) Product
 Table 129. Aspen Recent Developments/Updates
 Table 130. The Medicines Company Company Information
 Table 131. The Medicines Company Description and Business Overview
 Table 132. The Medicines Company Vitamin K Antagonists (VKA) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 133. The Medicines Company Vitamin K Antagonists (VKA) Product
 Table 134. The Medicines Company Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Vitamin K Antagonists (VKA) Distributors List
 Table 138. Vitamin K Antagonists (VKA) Customers List
 Table 139. Vitamin K Antagonists (VKA) Market Trends
 Table 140. Vitamin K Antagonists (VKA) Market Drivers
 Table 141. Vitamin K Antagonists (VKA) Market Challenges
 Table 142. Vitamin K Antagonists (VKA) Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Vitamin K Antagonists (VKA)
 Figure 2. Global Vitamin K Antagonists (VKA) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Vitamin K Antagonists (VKA) Market Share by Type: 2024 & 2031
 Figure 4. Oral Vitamin K Antagonists Product Picture
 Figure 5. Injection Vitamin K Antagonists Product Picture
 Figure 6. Global Vitamin K Antagonists (VKA) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Vitamin K Antagonists (VKA) Market Share by Application: 2024 & 2031
 Figure 8. VTE
 Figure 9. ACS/MI
 Figure 10. AF
 Figure 11. Others
 Figure 12. Global Vitamin K Antagonists (VKA) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Vitamin K Antagonists (VKA) Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Vitamin K Antagonists (VKA) Sales (2020-2031) & (K MT)
 Figure 15. Global Vitamin K Antagonists (VKA) Average Price (USD/MT) & (2020-2031)
 Figure 16. Vitamin K Antagonists (VKA) Report Years Considered
 Figure 17. Vitamin K Antagonists (VKA) Sales Share by Manufacturers in 2024
 Figure 18. Global Vitamin K Antagonists (VKA) Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Vitamin K Antagonists (VKA) Players: Market Share by Revenue in Vitamin K Antagonists (VKA) in 2024
 Figure 20. Vitamin K Antagonists (VKA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Vitamin K Antagonists (VKA) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Vitamin K Antagonists (VKA) Sales Market Share by Country (2020-2031)
 Figure 23. North America Vitamin K Antagonists (VKA) Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Vitamin K Antagonists (VKA) Sales Market Share by Country (2020-2031)
 Figure 27. Europe Vitamin K Antagonists (VKA) Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Vitamin K Antagonists (VKA) Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Vitamin K Antagonists (VKA) Revenue Market Share by Region (2020-2031)
 Figure 35. China Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Vitamin K Antagonists (VKA) Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Vitamin K Antagonists (VKA) Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Vitamin K Antagonists (VKA) Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Vitamin K Antagonists (VKA) Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Vitamin K Antagonists (VKA) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Vitamin K Antagonists (VKA) by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Vitamin K Antagonists (VKA) by Type (2020-2031)
 Figure 57. Global Vitamin K Antagonists (VKA) Price (USD/MT) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Vitamin K Antagonists (VKA) by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Vitamin K Antagonists (VKA) by Application (2020-2031)
 Figure 60. Global Vitamin K Antagonists (VKA) Price (USD/MT) by Application (2020-2031)
 Figure 61. Vitamin K Antagonists (VKA) Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Acenocoumarol Market Research Report 2024
Global Vitamin K Market Research Report 2025
Global Nutritional Vitamin Drugs Market Research Report 2024
Vitamin K2 MK 7 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pyrroloquinoline Quinone Market Insights Forecast to 2030
Global Phytomenadione Market Research Report 2025
Global Menadione Vitamin K3 Market Research Report 2025
Global Nicoumalone Market Research Report 2024
Global Xanthotoxol Market Research Report 2024
Global Warfarin Market Insights Forecast to 2030
Global Vitamin B4 Active Pharmaceutical Ingredient Market Research Report 2025
Global Radotinib Market Research Report 2024
Global Vitamin B1 Thiamine Mononitrate Market Insights Forecast to 2030
Global Natural Vitamins Market Research Report 2025
Global Antioxidant Vitamins Market Research Report 2025
Global Vitamin K3 MNB Market Research Report 2024
Global Kinase Inhibitors Market Insights Forecast to 2030
Global Anticoagulant Drugs Market Insights Forecast to 2030
Global Vitamins and Minerals Market Insights Forecast to 2030
Global PIVKA II Antigen Market Research Report 2024

RELATED REPORTS

Global Taurine and Derivatives Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26D19461
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global OTC Hydrotalcite Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18S16538
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Women's Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14W1499
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Yohimbine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Y1251
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions